n-3 Fatty acids and cardiovascular disease: Mechanisms underlying beneficial effects

American Journal of Clinical Nutrition

Volumn 87, Issue 6, 2008, Pages

  Un, Ju Jung ^a   Torrejon, Claudia ^a   Tighe, Ann P ^b   Deckelbaum, Richard J ^a  

^a Columbia University ^*  (United States)

^b Scientiae LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LIPID; LIPOPROTEIN; OMEGA 3 FATTY ACID;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CLINICAL STUDY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; FAT INTAKE; HEART PROTECTION; HUMAN; IN VITRO STUDY; INFLAMMATION; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; NONHUMAN; OBSERVATIONAL STUDY; THROMBOCYTE FUNCTION;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; DIETARY PROTEINS; FATTY ACIDS, OMEGA-3; FISH OILS; FISHES; HUMANS; HYPERTENSION; MYOCARDIAL INFARCTION;

ANIMALIA;

EID: 45749085203     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (98)

1. Burr ML, Fehily AM, Gilbert JF, et al. Effect of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet And Reinfarction Trial (DART). Lancet 1989;2:757-61.
2. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther 1997;11:485-91.
3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico [Italian group for the study of the survival of myocardial infarction]. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55.
4. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis, Lancet 2007;369:1090-8.
5. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B. N-3 fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcome in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006;84:5-17.
6. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risk and the benefits. JAMA 2006;296:1885-99.
7. Wilkinson P, Leach C, Ah-Sing EE. Influence of α-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype. Atherosclerosis 2005;181:115-24.
8. Wendland E, Farmer A, Glasziou P, Neil A. Effect of α-linolenic acid on cardiovascular risk markers: a systematic review. Heart 2006;92:166-9.
9. Connor WE. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 2000;71(suppl):S171-5.
10. Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003;107:2646-52.
11. Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65(suppl):S1645-54.
12. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002;20:1493-9.
13. Knapp HR. Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 1997;65(suppl):S1687-98.
14. Seo T, Qi K, Chang C, Worgall TS, Ramakrishnan R, Deckelbaum RJ. Saturated fat-rich diet enhances selective uptake of LDL cholesteryl esters in the arterial wall. J Clin Invest 2005;115:2214-22.
15. Goodfellow J, Bellamy MF, Ramsey MW, Jones CJ, Lewis MJ. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 2000;35:265-70.
16. Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001;36:1007-24.
17. Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci 2004;107:1-11.
18. Rudel LL, Parks JS, Hedrick CC, Thomas M, Williford K. Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates. Role of cholesterol and fatty acids. Prog Lipid Res 1998;37:353-70.
19. Guallar E, Aro A, Jiménez FJ, et al. Omega-3 fatty acids in adipose tissue and risk of myocardial infarction; the EURAMIC study. Arterioscler Thromb Vasc Biol 1999;19:1111-8.
20. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol 1995;25:387-94.
21. Akabas SR, Deckelbaum RJ. Summary of a workshop on n-3 fatty acids: current status of recommendations and future directions. Am J Clin Nutr 2006;83(suppl 6):S1536-8.
22. Morris MC, Manson JE, Rosner B, Buring JE, Willett WC, Hennekens CH. Fish consumption and cardiovascular disease in the physicians' health study: a prospective study. Am J Epidemiol 1995;142:166-75.
23. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl H Med 1995;332:977-82.
24. Lapidus L, Andersson H, Bengtsson C, Bosaeus I. Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Clin Nutr 1986;44:444-8.
25. Von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care 2007;10:129-35.
26. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106: 2747-57.
27. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in woman: 2007 update. Circulation 2007;115:1481-501.
28. US Food and Drug Administration. Docket No. 91N-0103. Internet: http://www.cfsan.fda.gov/∼dms/ds-ltr11.html (accessed 31 October 2000).
29. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003;107: 1372-7.
30. Mozaffarian D, Psaty BM, Rimm EB, et al. Fish intake and risk of incident atrial fibrillation. Circulation 2004;110:368-73.
31. Mozaffarian D, Ascherio A, Hu FB, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005;111:157-64.
32. Mozaffarian D, Bryson CL, Lemaitre RN, Burke GL, Siscovick DS. Fish intake and risk of incident heart failure. J Am Coll Cardiol 2005;45: 2015-21.
33. Mills SC, Windsor AC, Knight SC. The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes. Clin Exp Immunol 2005;142:216-28.
34. von Schacky C, Weber PC. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 1985;76:2446-50.
35. Botham KM, Zheng X, Napolitano M, et al. The effects of dietary n-3 polyunsaturated fatty acids delivered in chylomicron remnants on the transcription of genes regulating synthesis and secretion of very-low-density lipoprotein by the liver: modulation by cellular oxidative state. Exp Biol Med 2003;228:143-51.
36. Deckelbaum RJ, Worgall TS, Seo T. n-3 Fatty acids and gene expression. Am J Clin Nutr 2006;83(suppl):S1520-25.
37. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897-903.
38. Bucher HC, Hengstler P, Schindler C, Meier G. n-3 Polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298-304.
39. McLennan PL. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr 1993;57:207-12.
40. McLennan PL, Bridle TM, Abeywardena MY, Charnock JS. Comparative efficacy of n-3 and n-6 polyunsaturated fatty acids in modulating ventricular fibrillation threshold in marmoset monkeys. Am J Clin Nutr 1993;58:666-9.
41. Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci USA 1994; 91:4427-30.
42. Schrepf R, Limmert T, Claus Weber P, Theisen K, Sellmayer A. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004;363:1441-2.
43. Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005; 112:2762-8.
44. Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. JAMA 2005;293:2884-91.
45. Brouwer IA, Zock PL, Camm AJ. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the study on omega-3 fatty acids and ventricular arrhythmia (SOFA) randomized trial. JAMA 2006;295:2613-9.
46. Leaf A. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Fundam Clin Pharmacol 2006;20:525-38.
47. Leaf A. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. J Cardiovasc Med 2007;8:S27-9.
48. Hokanson JE, Austin MA. Plasma trigyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-9.
49. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006;189:19-30.
50. Bays H, Stein EA. Pharmacotherapy for dyslipidaemia-current therapies and future agents. Expert Opin Pharmacother 2003;4:1901-38.
51. Harper C, Jacobson T. An evidence-based approach to the use of combination drug therapy for mixed dyslipidemia. J Clin Outcomes Manage 2006;13:57-68.
52. Huff MW, Telford DE. Dietary fish oil increases the conversion of VLDL apoB to LDL apoB. Arteriosclerosis 1989;9:58-66.
53. Schectman G, Kaul S, Kissebah AH. Heterogeneity of low density lipoprotein responses to fish-oil supplementation in hypertriglyceridemic subjects. Arteriosclerosis 1989;9:345-54.
54. Lada AT, Rudel LL, St ClaireR W. Effect of LDL enriched with different dietary fatty acids on cholesteryl ester accumulation and turnover in THP-1 macrophages. J Lipid Res 2003;44:770-9.
55. Parks JS, Bullock BC. Effect of fish oil versus lard diets on the chemical and physical properties of low density lipoproteins of nonhuman primates. J Lipid Res 1987;28:1773-82.
56. Parks JS, Gebre AK, Edwards IJ, Wagner WD. Role of LDL subfraction heterogeneity in the reduced binding of low density lipoproteins to arterial proteoglycans in cynomolgus monkeys fed a fish oil diet. J Lipid Res 1991;32:2001-8.
57. Edwards IJ, Gebre AK, Wagner WD, Parks JS. Reduced proteoglycan binding of low density lipoproteins from monkeys (Macaca fascicularis) fed a fish oil versus lard diet. Arterioscler Thromb 1991;11:1778-85.
58. Densupsoontorn N, Worgall TS, Seo T, Carpentire YA, Deckelbaum RJ. Fatty acid supplied as triglyceride regulates SRE-mediated gene expression as efficiently as free fatty acids. Lipids 2007;42:885-91.
59. Sampath H, Ntambi J. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr 2005;25:317-40.
60. Harris W, Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 2006;17:387-93.
61. Worgall TS, Sturley SL, Seo T, Osborne TF, Deckelbaum RJ. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element binding protein. J Biol Chem 1998;273:25 537-40.
62. Ren B, Thelen A, Peters J, Gonzalez FJ, Jump DB. Polyunsaturated fatty acid suppression of hepatic fatty acid. Synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J Biol Chem 1997;272:26 827-32.
63. Khan S, Minihane AM, Talmud PJ, et al. Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype. J Lipid Res 2002;43:979-85.
64. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523-33.
65. Engler MM, Engler MB, Goodfriend TL, et al. Docosahexaenoic acid is an antihypertensive nutrient that affects aldosterone production in SHR. Proc Soc Exp Biol Med 1999;221:32-8.
66. Engler MM, Engler MB, Pierson DM, Molteni LB, Molteni A. Effects of docosahexaenoic acid on vascular pathology and reactivity in hypertension. Exp Biol Med 2003;228:229-307.
67. Engler MB, Engler MM. Docosahexaenoic acid-induced vasorelaxation in hypertensive rats: mechanisms of action. Biol Res Nurs 2000;2:85-95.
68. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 2005;112:1945-52.
69. Oosthuizen W, Vorster HH, Jerling JC, et al. Both fish oil and olive oil lowered plasma fibrinogen in women with high baseline fibrinogen levels. Thromb Haemost 1994;72:557-62.
70. Shahar E, Folsom AR, Wu KK, et al. Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb 1993;13:1205-12.
71. Thompson SG, Kienast J, Pyke SD, Haverkate F, Van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-41.
72. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 2003;361:477-85.
73. Brown MS, Goldstein JL. A receptor mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
74. Seo T, St Clair RW. Heparan sulfate proteoglycan mediated internalization and degradation of beta-VLDL and promote cholesterol accumulation by pigeon macrophages. J Lipid Res 1997;38:765-79.
75. Han J, Hajjar DP, Febbraio M, Nicholson AC. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem 1997;272: 21 654-9.
76. Seo T, Al-Haideri M, Treskova E, et al. Lipoprotein lipase-mediated selective uptake from low density lipoprotein requires cell surface proteoglycans and is independent of scavenger receptor classBtype 1. J Biol Chem 2000;275:30 355-62.
77. Steinberg D. A docking receptor for HDL cholesterol esters. Science 1996;271:460-1.
78. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Goldberg IJ, Steinberg D, Witztum JL. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991;88:10143-7.
79. Haug A, Hostmark AT. Lipoprotein lipases, lipoproteins and tissue lipids in rats fed fish oil or coconut oil. J Nutr 1987;117:1011-7.
80. Michaud SE, Renier G. Direct regulatory effect of fatty acids on macrophage lipoprotein lipase potential role of PPARs. Diabetes 2001;50: 660-6.
81. Terano T, Shiina T, Tamura Y. Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals. Lipids 1996;31(suppl):S301-4.
82. Nakayama M, Fukuda N, Watanabe Y, et al. Low dose eicosapentaenoic acid inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats through suppression of transforming growth factor-β. J Hypertens 1999;17:1421-30.
83. Morisaki N, Sprecher H, Milo GE, Cornwell DG. Fatty acid specificity in the inhibition of cell proliferation and its relationship to lipid peroxidation and prostaglandin biosynthesis. Lipids 1982;17:893-9.
84. Cooke JP. The endothelium: a new target for therapy. Vasc Med 2000; 5:49-53.
85. Brown AA, Hu FB. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001;73:673-86.
86. Israel DH, Gorlin R. Fish oils in the prevention of atherosclerosis. J Am Coll Cardiol 1992;19:174-85.
87. Fleischhauer FJ, Yan WD, Fischell TA. Fish oil improves endothelium-dependent coronary vasodilation in heart transplant recipients. J Am Coll Cardiol 1993;21:982-9.
88. Abeywardena MY, Head RJ. Long chain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc Res 2001;52:361-71.
89. 2+-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett 2001;487:361-6.
90. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
91. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 2002;8:1249-56.
92. Prichard BN, Smith CCT, Ling KL, Betteridge DJ. Fish oils and cardiovascular disease. BMJ 1995;310:819-20.
93. De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000;71(suppl 1):S213-23.
94. Weldon SM, Mullen AC, Loscher CE, Hurley LA, Roche HM. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem 2007;18:250-8.
95. Baumann KH, Hessel F, Larass I, et al. Dietary ω-3, ω-6, and ω-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. A randomized volunteer study. Arterioscler Thromb Vasc Biol 1999;19:59-66.
96. Holm T, Berg RK, Andreassen AK, et al. Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients. Transplantation 2001;72:706-11.
97. Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996;97:1715-22.
98. Ricote M, Valledor AF, Glass CK. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:230-9.